SIStefan Ilic

Stefan Ilic

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefan Ilic has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Invasive Management and 1-Year Outcomes in Patients Aged ≥75 Years with Acute Coronary Syndrome: Age and Clinical Vulnerability

    by Dragana Stanojevic, Svetlana Apostolovic, Stefan Ilic, Bojan Maricic, Sonja Dakic, Jelena Perisic, Danica Milosevic, Tamara Filipovic, Bane Spasovic, Katarina Kostic, et al.

    Background/Objectives: Older adults with acute coronary syndrome (ACS) are clinically heterogeneous, and treatment decisions should not rely on chronological age alone. We examined associations of age and clinical vulnerability with coronary angiography, subsequent percutaneous coronary intervention (PCI), and mortality in patients aged ≥75 years. Methods: We retrospectively studied 1043 consecutive patients hospitalized with ACS between January 2021 and April 2026. Clinical vulnerability was assessed using the exploratory, study-specific Senior ACS Clinical Vulnerability Score (SAF-75). Results: Mean age was 81.0 years; 47.6% were women. Coronary angiography was performed in 571 patients (54.7%) and PCI in 208 (19.9%). Angiography declined from 68.6% at age 75–79 years to 30.1% at ≥85 years. Age was independently associated with lower odds of angiography (OR 0.86 per year, 95% CI 0.82–0.89; p < 0.001), but not with subsequent PCI among patients undergoing angiography (OR 1.01, 95% CI 0.95–1.06; p = 0.852). In-hospital and Kaplan–Meier estimated 1-year mortality were 18.1% and 35.7%. Greater vulnerability was associated with lower angiography use and higher mortality; no independent association with PCI after angiography was detected. Conclusions: Age-related and vulnerability-related differences were most evident at angiography selection. SAF-75 was strongly associated with prognosis but requires external validation.

  • Open Access

    Malignancy as a Predictor and Potential Modifier of Laboratory Biomarker Prognostic Value in Acute Pulmonary Embolism

    by Sonja Salinger, Aleksandra Kozic, Stefan Ilic, Boris Dzudovic, Bojana Subotic, Jovan Matijasevic, Marija Benic, Tamara Kovacevic Preradovic, Ana Kovacevic-Kuzmanovic, Irena Mitevska, et al.

    Background/Objectives: Acute pulmonary embolism (PE) is a major cause of cardiovascular mortality, with prognosis influenced by hemodynamic status, comorbidities, and biomarker profiles. Although several laboratory markers have demonstrated prognostic relevance in PE, it remains unclear whether their predictive performance differs in patients with active malignancy. This study aimed to identify laboratory predictors of in-hospital mortality in acute PE and evaluate the modifying effect of malignancy on biomarker-based prognostic stratification. Methods: This retrospective multicenter cohort study included 2803 consecutive patients with confirmed acute PE enrolled in the Regional Pulmonary Embolism Registry (REPER) between January 2015 and April 2026. Univariate and multivariable logistic regression analyses were performed to identify predictors of in-hospital mortality in the overall cohort and subgroups stratified by malignancy status. Interaction analyses were used to formally assess effect modification by malignancy. Results: Active malignancy was present in 14.02% of patients, and overall in-hospital mortality was 11.10%. Multivariable analysis identified malignancy, CRP, glucose, creatinine clearance (CrCl), platelet count, and ESC risk category as independent predictors of in-hospital mortality. In-hospital mortality was significantly higher in patients with malignancy compared with those without (16.54% vs. 10.21%, p < 0.001). In the malignant subgroup, CRP and glucose remained independent predictors, whereas in non-malignant patients, CRP, glucose, CrCl, and ESC risk category were independently associated with outcome. Significant interactions between malignancy status and CrCl, age, glucose, and total leukocyte count suggest that the prognostic contribution of these variables may differ according to cancer status. Conclusions: Active malignancy is an independent predictor of in-hospital mortality in acute PE and appears to be associated with a more severe presentation. Our findings suggest that malignancy may also modify the prognostic performance of certain biomarkers. These observations suggest that conventional risk stratification tools may require cautious, malignancy-aware interpretation and that prospective studies validating malignancy-adapted prognostic frameworks are warranted.

  • Open Access

    Malignancy as a Predictor and Potential Modifier of Laboratory Biomarker Prognostic Value in Acute Pulmonary Embolism

    by Sonja Salinger, Aleksandra Kozic, Stefan Ilic, Boris Dzudovic, Bojana Subotic, Jovan Matijasevic, Marija Benic, Tamara Kovacevic, Ana Kovacevic-Kuzmanovic, Irena Mitevska, et al.

    Background/Objectives: Acute pulmonary embolism (PE) is a major cause of cardio-vascular mortality, with prognosis influenced by hemodynamic status, comorbidities, and biomarker profiles. Although several laboratory markers have demonstrated prog-nostic relevance in PE, it remains unclear whether their predictive performance differs in patients with active malignancy. This study aimed to identify laboratory predictors of in-hospital mortality in acute PE and to evaluate the modifying effect of malignancy on biomarker-based prognostic stratification. Methods: This retrospective multicenter cohort study included 2803 consecutive patients with computed tomography-confirmed acute PE enrolled in the Regional Pulmonary Embolism Registry (REPER) between January 2015 and April 2026. Univariate and multivariable logistic regression analyses were performed to identify predictors of in-hospital mortality in the overall cohort and in subgroups stratified by malignancy status. Interaction analyses were used to assess effect modification by malignancy. Results: Active malignancy was present in 14.02% of patients, while overall in-hospital mortality was 14.93%. In the overall cohort, multivariable analysis identified malignancy (OR 1.698, 95% CI 1.128–2.555, p = 0.011), C-reactive protein (CRP), glucose, creatinine clearance (CrCl), platelet count, and white blood cell count as independent predictors of in-hospital mortality (BNP was excluded from multivariable models due to missing data). Mortality was significantly higher in patients with ma-lignancy compared with those without (20.9% vs. 13.2%, p < 0.001). In patients with malignancy, CRP and glucose remained independent predictors, whereas in non-malignant patients, CRP, glucose, and CrCl were independently associated with mortality. Significant interaction effects were observed for CrCl, age, glucose, and white blood cell count. Conclusions: Malignancy is an important predictor of in-hospital mortality in acute PE and may partially influence the prognostic performance of certain conventional biomarkers. These findings suggest that while standard risk markers remain broadly reliable, specific parameters might benefit from a cautious, malignancy-aware interpretation.

  • Open Access

    ROLE OF PROTEIN C IN PROGNOSTIC EVALUATION OF ACUTE PANCREATITIS

    by Biljana Radovanović Dinić, Snežana Tešić Rajković, Stefan Ilić, Goran Marjanović, Valentina Živković

    The aim of this study was to investigate the significance of early determination of protein C values in assessing the severity of acute pancreatitis (AP).The prospective study included 92 patients with AP. The patients were divided into three groups based on the criteria of the revised Atlanta Classification. All patients were further classified into two groups: group A (mild AP) and group B (moderate and severe AP). Biochemical markers, inflammatory biomarkers, and Protein C were tested in all patients. Based on the results of the Mann-Whitney test it can be concluded that a statistically significant difference exists between groups A and B for CRP and protein C (p<0.05). We verified the statistically significant correlation between protein C and lipase (Spearman R 0.467: p 0.000) and CRP (Spearman R 0.463: p 0.000). Based on binary logistic regression, the accuracy of CRP in predicting severe AP is 83%. The sensitivity of protein C in differentiating mild, moderate and severe AP, was 100%, and the specificity was 100% for the cut-off value of 39%. Protein C as a single parameter may be an early indicator of the severity of AP.

  • Open Access

    FORENSIC AND SOCIOEPIDEMIOLOGICAL ASPECT OF STRAY DOGS BITES

    by Miroslav Milić, Miodrag Zdravković, Aleksandra Antović, Milica Miljković, Katarina Randjelovic, Stefan Ilić

    Dog bites represent an increasingly significant medical, public health, and legal issue, particularly in urban areas with a high number of stray dogs. Alongside actual injuries, there is a growing number of false bite reports aimed at obtaining unlawful financial compensation. This study aimed to analyze the characteristics of injuries reported as dog bites in southeastern Serbia during 2022, determine the frequency of falsely reported cases, and identify changes in dog bite frequency in 2023 and 2024. Data were collected from the Institute of Forensic Medicine in Niš, including 443 reported cases. Each case was analyzed for cause, type, location of injury, and demographic characteristics of the injured individuals. In 87.58% of cases, the bite was confirmed as authentic, while 4.74% were determined to be falsely reported. Individuals aged 51 to 70 years were most frequently affected, and the lower limbs were the most common injury location. Most injuries were minor and occurred in the afternoon. No statistically significant change in the frequency of false reporting was observed from 2022 to 2024. The calculated slope of -12.50 and p-value of 0.6166 indicate no statistically significant trend in total dog bite reports. This study highlights the need for a systematic approach, including improved stray dog control, enhanced shelter infrastructure, and the development of forensic protocols to distinguish between real and false bite injuries. Such measures could reduce both the legal and financial burden on local communities.